The 6-iodo 9 was more potent against EGFR (IC50 = 0.83 μM), but was still weak in the four additional chordoma cell lines (IC50 = > 100 μM) and WS1 (IC50 = 98 μM). The gene discussed is EGFR; the disease is chordoma.